Matsuura Y

No ORCID on file · 4 papers in corpus · active 2006-2023

Study types

  • article 1
2023
The Changes in Menstrual and Menstrual-Related Symptoms among Japanese Female University Students: A Prospective Cohort Study from Three Months to Nine Months after Admission.
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare11182557

Menstrual and menstrual-related symptoms can significantly impact an individual's physical and psychological health. Understanding how these symptoms evolve over time is crucial to provide appropriate support and healthcare services to youn…

2022
Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer.
Frontiers in oncology ·doi:10.3389/fonc.2022.1079716

BackgroundLenvatinib-pembrolizumab combination (LEAP) is an approved therapy in Japan for advanced endometrial cancer, based on the data from the KEYNOTE-775 clinical trial. We report a case of posterior reversible encephalopathy syndrome (…

2010
Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance.
Virchows Archiv : an international journal of pathology ·doi:10.1007/s00428-010-0895-7

Mitochondrial transcription factor A (mtTFA) is necessary for both transcription and maintenance of mitochondrial DNA. This study was conducted to elucidate the clinicopathologic and prognostic significance of mtTFA in patients with endomet…

article 2006
Thromboembolic complications in patients with clear cell carcinoma of the ovary
Gynecologic oncology ·doi:10.1016/j.ygyno.2006.08.026

ObjectiveThe purpose of this study was to define the incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients with clear cell carcinoma (CCC) of the ovary and to investigate the prognostic factors in such patients.M…